Morgan Stanley downgraded Medacta Group to Equal Weight from Overweight with a price target of CHF 113, up from CHF 106. The analyst cites valuation for the downgrade with the shares up over 50% since October.
Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>